A detailed history of Jacob Asset Management Of New York LLC transactions in Scynexis Inc stock. As of the latest transaction made, Jacob Asset Management Of New York LLC holds 50,000 shares of SCYX stock, worth $50,000. This represents 0.16% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$50,000
Previous $147,000 23.13%
% of portfolio
0.16%
Previous 0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$2.38 - $3.67 $119,000 - $183,500
50,000 New
50,000 $147,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $32.7M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Jacob Asset Management Of New York LLC Portfolio

Follow Jacob Asset Management Of New York LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.